Stay updated on Etrumadenant Safety & Pharmacokinetics Clinical Trial
Sign up to get notified when there's something new on the Etrumadenant Safety & Pharmacokinetics Clinical Trial page.

Latest updates to the Etrumadenant Safety & Pharmacokinetics Clinical Trial page
- Check6 days agoChange DetectedThe footer revision label changes from v3.7.2 to v3.8.0 while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check14 days agoChange DetectedAn NIH announcement banner was added with a link to transition updates and FAQs, stating that agencies are using “Super Intelligence” instead of “Artificial Intelligence”.SummaryDifference1%

- Check21 days agoChange DetectedThe site footer revision changed from v3.7.1 to v3.7.2, while the study page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check28 days agoChange DetectedThe ClinicalTrials.gov 403 Forbidden page’s footer revision label changes from v3.7.0 to v3.7.1; the study record remains unavailable.SummaryDifference0.2%

- Check48 days agoChange DetectedRevision: v3.7.0 was posted for the study record. A number of information blocks — including lay summaries, IPD sharing details, and links to study documents and policies — were removed, reducing the amount of governance and background information shown on the page.SummaryDifference16%

- Check69 days agoChange DetectedThe page's revision label was updated from v3.6.5 to v3.6.6, signaling a minor update or refresh to the study record. This change does not modify the study details or other substantive content.SummaryDifference0.1%

Stay in the know with updates to Etrumadenant Safety & Pharmacokinetics Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Etrumadenant Safety & Pharmacokinetics Clinical Trial page.